OR WAIT null SECS
Snøve, an investment director for Aker BioMarine ASA, replaces former Epax CEO Terje Bakken.
The board of directors at omega-3 concentrates supplier Epax AS (Oslo, Norway) named Ola Snøve its new CEO, the company announced Thursday.
Snøve, an investment director for Aker BioMarine ASA (Oslo), replaces Terje Bakken as Epax’s CEO, effective immediately. Aker is a joint venture between Epax and Lindsay Goldberg LLC (New York City).
With Snøve as its new CEO, Epax will continue its work in omega-3 concentrates and its development of a triglyceride-lowering drug.
Snøve’s background includes postdoctoral research at the Norwegian University of Science and Technology Department of Cancer Research and Molecular Biology and City of Hope’s Beckman Research Institute in California. He holds an MSc in mechanical engineering and a PhD in computer science from the Norwegian University of Science and Technology, and an MBA from INSEAD in France.